FDA Grants Marketing Authorization to At-Home Chlamydia and Gonorrhea Test

The test, which screens for chlamydia, gonorrhea, and trichomoniasis, delivers results in 30 minutes and was at least 97% effective in detecting each infection.

The FDA has granted marketing authorization to Visby Medical for the Visby Medical Women’s Sexual Health Test.

The test is the “first diagnostic test for chlamydia, gonorrhea, and trichomoniasis that can be purchased without a prescription and performed entirely at home.” It can deliver results in approximately 30 minutes.

According to the CDC, “more than 2.2 million cases of chlamydia and gonorrhea were diagnosed and reported in the U.S. in 2023. Additionally, it is estimated that trichomoniasis is the most prevalent nonviral STI worldwide, affecting approximately 2.6 million people in the U.S.” All three infections can typically be treated with antibiotics, “but if left untreated, [they] can cause serious health complications for patients, including infertility.”

The Visby Medical Women’s Sexual Health Test is a “single use, at home test, that includes a collection kit (self-collected vaginal swab) and a powered testing device, which communicates securely to the Visby Medical app, which displays results when the test is complete.” In those with and without symptoms, the test correctly identified 97% to 100% of the negative and positive results for the three infections. Individuals with positive results should seek medical care, and those with concerns despite a negative result “should contact their healthcare provider for additional testing.”

About the Author

Matt MacKenzie

Matt MacKenzie

Associate Editor

Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care. 

Sign up for our eNewsletters
Get the latest news and updates

Related